Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0MM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,804
Award facts
- Contract value 100% obligated
- $27,803.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,803.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Stelara 45 mg/0.5 mL syringes on January 16, 2026, with an ultimate completion date of January 20, 2026. This contract was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This contract structure demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements through competitive procurement and its role as a critical vendor supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FR0MM?
SPE2DR26FR0MM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FR0MM worth?
The government has obligated $27,804 on SPE2DR26FR0MM.
Is contract SPE2DR26FR0MM an order under another contract?
Yes. SPE2DR26FR0MM is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0MM competed?
The extent of competition for SPE2DR26FR0MM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award